Sexually transmitted infections (STIs) are infections transmitted primarily through sexual contact, including vaginal, anal, and oral sex, as well as through skin-to-skin contact in some cases. The term STI encompasses a broad group of bacterial, viral, and parasitic diseases. Common bacterial STIs include chlamydia and gonorrhea; treatable with antibiotics when correctly prescribed and taken. Syphilis is caused by Treponema pallidum and requires specific antibiotic regimens. Viral STIs include herpes simplex virus (HSV), human papillomavirus (HPV), and human immunodeficiency virus (HIV); these require antiviral therapy for suppression or control and, in some settings, curative strategies are limited. Parasitic STIs include trichomoniasis, treated with antiprotozoals. A key educational point is that while some STIs are curable with appropriate medication, not all are, and sex itself is not a universal cure.
The viral statement that “only sex can cure” reflects a widespread misconception. Transmission and treatment are distinct biological processes: sex is a route of exposure, not a pharmacologic mechanism of cure. For curable bacterial infections, symptoms may improve with time, but eradication depends on antimicrobial effectiveness against the pathogen, adequate dosing, and adherence. For instance, inadequate treatment can select for resistant strains or permit persistent infection, increasing risks such as pelvic inflammatory disease (PID), infertility, epididymitis, and ectopic pregnancy. Gonorrhea has demonstrated antimicrobial resistance globally, making guideline-based antibiotic choice critical. Chlamydia can be asymptomatic yet still cause reproductive tract damage, which underscores why testing and treatment are essential even when symptoms are mild or absent.
Viral STIs illustrate why “sex as cure” is biologically implausible. HSV establishes latency in sensory ganglia; antiviral drugs such as acyclovir, valacyclovir, or famciclovir reduce viral replication and decrease episode frequency, but they do not eliminate latent virus. HPV can clear spontaneously in many individuals, but persistent infection can drive dysplasia and malignancy risk. There is no “cure by sex”; the role of sex is in transmission probability and in risk reduction through condoms, mutual monogamy with testing, and vaccination. HIV, through effective antiretroviral therapy (ART), can achieve viral suppression to undetectable levels and dramatically reduces transmission risk, but it requires long-term medication. Discontinuing ART risks viral rebound and disease progression.
From a public health perspective, STIs are managed through diagnosis, partner notification, and preventive interventions. Syndromic management (treating based on symptoms) can be useful in settings with limited testing, but it may miss co-infections and fails to address antimicrobial resistance patterns. Nucleic acid amplification tests (NAATs) for chlamydia and gonorrhea offer high sensitivity and specificity. Serologic testing is used for syphilis and HIV. For HPV-related disease, cervical screening and management of precancerous lesions are central. Partner notification is medically important because reinfection after treatment is common when partners are untreated.
Psychological and behavioral drivers also shape STI risk. Stigma can delay care, while fatalistic beliefs (“there is no point getting tested”) can undermine prevention. Social media narratives can intensify misinformation by framing sex as a remedy. Health communication must emphasize that prevention and treatment are grounded in evidence-based therapeutics: antibiotics for susceptible bacteria, antivirals for viral replication control, and antiparasitics for protozoal infections. Condom use reduces risk but does not eliminate it because some infections transmit through skin contact. Vaccines are a major advancement: HPV vaccination reduces risk of cervical, anal, and other cancers, and hepatitis B vaccination helps prevent a related sexually transmissible viral infection.
In clinical practice, counseling includes screening recommendations based on sexual history, age, pregnancy, and prior infection. Risk assessment may indicate periodic testing even without symptoms. Treatment should include abstaining from sex until therapy is completed and symptoms resolve where appropriate, and ensuring partners receive evaluation. Treatment also should address reinfection risks through education and follow-up.
It is important to recognize that sexual health advice should not be reduced to simplistic “cures.” Many STIs are not cured by sexual activity; instead, appropriate medical therapy cures certain infections, suppresses viral disease, and prevents complications. When someone suspects an STI—new discharge, genital ulcers, burning urination, pelvic pain, or abnormal bleeding—timely medical evaluation and testing are the evidence-based path to recovery.
Source: @zamaniii00
Samson🇳🇬🇳🇬🇳🇬: imagine another virus comes out, and it is only sex that can cure it, some mum will be like “Samson dakun bami do Omo yi daádá, aburo re naa ni” 😂😂. #breaking
— @zamaniii00 May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
